ID   AAAT_HUMAN              Reviewed;         541 AA.
AC   Q15758; A8K9H5; B4DR77; B4DWS4; B7ZB81; D0EYG6; E9PC01; O95720; Q96RL9;
AC   Q9BWQ3; Q9UNP2;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   20-JUN-2002, sequence version 2.
DT   11-DEC-2019, entry version 195.
DE   RecName: Full=Neutral amino acid transporter B(0);
DE            Short=ATB(0);
DE   AltName: Full=Baboon M7 virus receptor;
DE   AltName: Full=RD114/simian type D retrovirus receptor;
DE   AltName: Full=Sodium-dependent neutral amino acid transporter type 2;
DE   AltName: Full=Solute carrier family 1 member 5;
GN   Name=SLC1A5; Synonyms=ASCT2, M7V1, RDR, RDRC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND SUBCELLULAR LOCATION.
RC   TISSUE=Choriocarcinoma;
RX   PubMed=8702519; DOI=10.1074/jbc.271.31.18657;
RA   Kekuda R., Prasad P.D., Fei Y.-J., Torres-Zamorano V., Sinha S.,
RA   Yang-Feng T.L., Leibach F.H., Ganapathy V.;
RT   "Cloning of the sodium-dependent, broad-scope, neutral amino acid
RT   transporter Bo from a human placental choriocarcinoma cell line.";
RL   J. Biol. Chem. 271:18657-18661(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION AS A VIRAL RECEPTOR
RP   (MICROBIAL INFECTION).
RX   PubMed=10051606; DOI=10.1073/pnas.96.5.2129;
RA   Rasko J.E.J., Battini J.L., Gottschalk R.J., Mazo I., Miller A.D.;
RT   "The RD114/simian type D retrovirus receptor is a neutral amino acid
RT   transporter.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:2129-2134(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION AS A VIRAL RECEPTOR
RP   (MICROBIAL INFECTION).
RX   PubMed=10196349;
RA   Tailor C.S., Nouri A., Zhao Y., Takeuchi Y., Kabat D.;
RT   "A sodium-dependent neutral-amino-acid transporter mediates infections of
RT   feline and baboon endogenous retroviruses and simian type D retroviruses.";
RL   J. Virol. 73:4470-4474(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Ouyang D.-Y., Xu L.-H., He X.-H., Zha Q.-B., Guo H., Gao Q., Zhang Y.-T.;
RT   "Cloning of ASCT2 cDNA from MCF-7 cells and its expression in B16 cells.";
RL   Submitted (SEP-2009) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3), AND VARIANT
RP   LEU-512.
RC   TISSUE=Esophagus, and Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M.,
RA   Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S.,
RA   Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S.,
RA   Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H.,
RA   Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M.,
RA   Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M.,
RA   Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y.,
RA   Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N.,
RA   Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S.,
RA   Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T.,
RA   Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M.,
RA   Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y.,
RA   Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y.,
RA   Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T.,
RA   Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 14-541 (ISOFORM 1), AND ALTERNATIVE
RP   INITIATION.
RX   PubMed=11350958; DOI=10.1074/jbc.M100737200;
RA   Tailor C.S., Marin M., Nouri A., Kavanaugh M.P., Kabat D.;
RT   "Truncated forms of the dual function human ASCT2 neutral amino acid
RT   transporter/retroviral receptor are translationally initiated at multiple
RT   alternative CUG and GUG codons.";
RL   J. Biol. Chem. 276:27221-27230(2001).
RN   [10]
RP   FUNCTION.
RX   PubMed=10708449; DOI=10.1128/JVI.74.7.3321-3329.2000;
RA   Blond J.-L., Lavillette D., Cheynet V., Bouton O., Oriol G.,
RA   Chapel-Fernandes S., Mandrand B., Mallet F., Cosset F.-L.;
RT   "An envelope glycoprotein of the human endogenous retrovirus HERV-W is
RT   expressed in the human placenta and fuses cells expressing the type D
RT   mammalian retrovirus receptor.";
RL   J. Virol. 74:3321-3329(2000).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-535, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [12]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H., Mangini N.J.,
RA   Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R., Yamagishi S.,
RA   Shabanowitz J., Hearing V.J., Wu C., Appella E., Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-535, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-212.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-linked
RT   cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-503 AND SER-535, VARIANT
RP   [LARGE SCALE ANALYSIS] LEU-512, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-535, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-493, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-493; THR-494; SER-535 AND
RP   SER-539, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   FUNCTION, INTERACTION WITH ERVH48-1, AND SUBCELLULAR LOCATION.
RA   Sugimoto J., Sugimoto M., Bernstein H., Jinno Y., Schust D.;
RT   "A novel human endogenous retroviral protein inhibits cell-cell fusion.";
RL   Sci. Rep. 3:1462-1462(2013).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (3.10 ANGSTROMS) OF 158-230, AND SUBUNIT.
RX   PubMed=28424515; DOI=10.1038/nature22064;
RA   Canul-Tec J.C., Assal R., Cirri E., Legrand P., Brier S., Chamot-Rooke J.,
RA   Reyes N.;
RT   "Structure and allosteric inhibition of excitatory amino acid transporter
RT   1.";
RL   Nature 544:446-451(2017).
RN   [25]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.85 ANGSTROMS), FUNCTION, SUBCELLULAR
RP   LOCATION, TOPOLOGY, AND SUBUNIT.
RX   PubMed=29872227; DOI=10.1038/s41594-018-0076-y;
RA   Garaeva A.A., Oostergetel G.T., Gati C., Guskov A., Paulino C.,
RA   Slotboom D.J.;
RT   "Cryo-EM structure of the human neutral amino acid transporter ASCT2.";
RL   Nat. Struct. Mol. Biol. 25:515-521(2018).
CC   -!- FUNCTION: Sodium-dependent amino acids transporter that has a broad
CC       substrate specificity, with a preference for zwitterionic amino acids.
CC       It accepts as substrates all neutral amino acids, including glutamine,
CC       asparagine, and branched-chain and aromatic amino acids, and excludes
CC       methylated, anionic, and cationic amino acids (PubMed:8702519,
CC       PubMed:29872227). Through binding of the fusogenic protein syncytin-
CC       1/ERVW-1 may mediate trophoblasts syncytialization, the spontaneous
CC       fusion of their plasma membranes, an essential process in placental
CC       development (PubMed:10708449, PubMed:23492904).
CC       {ECO:0000269|PubMed:10708449, ECO:0000269|PubMed:23492904,
CC       ECO:0000269|PubMed:29872227, ECO:0000269|PubMed:8702519}.
CC   -!- FUNCTION: (Microbial infection) Acts as a cell surface receptor for
CC       Feline endogenous virus RD114. {ECO:0000269|PubMed:10051606,
CC       ECO:0000269|PubMed:10196349}.
CC   -!- FUNCTION: (Microbial infection) Acts as a cell surface receptor for
CC       Baboon M7 endogenous virus. {ECO:0000269|PubMed:10196349}.
CC   -!- FUNCTION: (Microbial infection) Acts as a cell surface receptor for
CC       type D simian retroviruses. {ECO:0000269|PubMed:10196349}.
CC   -!- SUBUNIT: Homotrimer (Probable) (PubMed:29872227). Interacts with
CC       ERVH48-1/suppressyn; may negatively regulate syncytialization
CC       (PubMed:23492904). {ECO:0000269|PubMed:23492904,
CC       ECO:0000269|PubMed:29872227, ECO:0000305|PubMed:28424515}.
CC   -!- INTERACTION:
CC       Q99942:RNF5; NbExp=4; IntAct=EBI-356576, EBI-348482;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:8702519,
CC       ECO:0000305|PubMed:29872227}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:29872227}. Melanosome. Note=Identified by mass
CC       spectrometry in melanosome fractions from stage I to stage IV.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing, Alternative initiation; Named isoforms=3;
CC         Comment=A number of isoforms are produced by alternative initiation.
CC         Isoforms start at multiple alternative CUG and GUG codons.
CC         {ECO:0000269|PubMed:11350958};
CC       Name=1;
CC         IsoId=Q15758-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15758-2; Sequence=VSP_046354;
CC       Name=3;
CC         IsoId=Q15758-3; Sequence=VSP_046851;
CC   -!- TISSUE SPECIFICITY: Placenta, lung, skeletal muscle, kidney, pancreas,
CC       and intestine.
CC   -!- SIMILARITY: Belongs to the dicarboxylate/amino acid:cation symporter
CC       (DAACS) (TC 2.A.23) family. SLC1A5 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U53347; AAC50629.1; -; mRNA.
DR   EMBL; AF102826; AAD09812.1; -; mRNA.
DR   EMBL; AF105423; AAD27806.1; -; mRNA.
DR   EMBL; GQ919058; ACX53626.1; -; mRNA.
DR   EMBL; AK292690; BAF85379.1; -; mRNA.
DR   EMBL; AK299137; BAG61189.1; -; mRNA.
DR   EMBL; AK301661; BAG63136.1; -; mRNA.
DR   EMBL; AK316546; BAH14917.1; -; mRNA.
DR   EMBL; AC008622; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471126; EAW57446.1; -; Genomic_DNA.
DR   EMBL; BC000062; AAH00062.1; -; mRNA.
DR   EMBL; AF334818; AAK77026.1; -; mRNA.
DR   CCDS; CCDS12692.1; -. [Q15758-1]
DR   CCDS; CCDS46125.1; -. [Q15758-2]
DR   CCDS; CCDS46126.1; -. [Q15758-3]
DR   RefSeq; NP_001138616.1; NM_001145144.1. [Q15758-3]
DR   RefSeq; NP_001138617.1; NM_001145145.1. [Q15758-2]
DR   RefSeq; NP_005619.1; NM_005628.2. [Q15758-1]
DR   PDB; 5LLM; X-ray; 3.25 A; A=158-230.
DR   PDB; 5LLU; X-ray; 3.32 A; A=158-230.
DR   PDB; 5LM4; X-ray; 3.10 A; A=158-230.
DR   PDB; 5MJU; X-ray; 3.71 A; A=158-230.
DR   PDB; 6GCT; EM; 3.85 A; A/B/C=1-541.
DR   PDB; 6RVX; EM; 3.61 A; A/B/C=1-541.
DR   PDB; 6RVY; EM; 4.13 A; A/B/C=1-541.
DR   PDBsum; 5LLM; -.
DR   PDBsum; 5LLU; -.
DR   PDBsum; 5LM4; -.
DR   PDBsum; 5MJU; -.
DR   PDBsum; 6GCT; -.
DR   PDBsum; 6RVX; -.
DR   PDBsum; 6RVY; -.
DR   SMR; Q15758; -.
DR   BioGrid; 112401; 92.
DR   IntAct; Q15758; 73.
DR   MINT; Q15758; -.
DR   STRING; 9606.ENSP00000444408; -.
DR   BindingDB; Q15758; -.
DR   ChEMBL; CHEMBL3562162; -.
DR   DrugBank; DB00174; Asparagine.
DR   DrugBank; DB13146; Fluciclovine (18F).
DR   DrugBank; DB00130; L-Glutamine.
DR   GuidetoPHARMACOLOGY; 874; -.
DR   TCDB; 2.A.23.3.3; the dicarboxylate/amino acid:cation (na(+) or h(+)) symporter (daacs) family.
DR   GlyConnect; 1562; -.
DR   iPTMnet; Q15758; -.
DR   PhosphoSitePlus; Q15758; -.
DR   SwissPalm; Q15758; -.
DR   BioMuta; SLC1A5; -.
DR   DMDM; 21542389; -.
DR   EPD; Q15758; -.
DR   jPOST; Q15758; -.
DR   MassIVE; Q15758; -.
DR   MaxQB; Q15758; -.
DR   PaxDb; Q15758; -.
DR   PeptideAtlas; Q15758; -.
DR   PRIDE; Q15758; -.
DR   ProteomicsDB; 19331; -.
DR   ProteomicsDB; 5376; -.
DR   ProteomicsDB; 60744; -. [Q15758-1]
DR   ABCD; Q15758; -.
DR   DNASU; 6510; -.
DR   Ensembl; ENST00000412532; ENSP00000397924; ENSG00000105281. [Q15758-3]
DR   Ensembl; ENST00000434726; ENSP00000406532; ENSG00000105281. [Q15758-2]
DR   Ensembl; ENST00000542575; ENSP00000444408; ENSG00000105281. [Q15758-1]
DR   GeneID; 6510; -.
DR   KEGG; hsa:6510; -.
DR   UCSC; uc002pfr.4; human. [Q15758-1]
DR   CTD; 6510; -.
DR   DisGeNET; 6510; -.
DR   EuPathDB; HostDB:ENSG00000105281.12; -.
DR   GeneCards; SLC1A5; -.
DR   HGNC; HGNC:10943; SLC1A5.
DR   HPA; HPA035239; -.
DR   HPA; HPA035240; -.
DR   MIM; 109190; gene.
DR   neXtProt; NX_Q15758; -.
DR   OpenTargets; ENSG00000105281; -.
DR   PharmGKB; PA35830; -.
DR   eggNOG; KOG3787; Eukaryota.
DR   eggNOG; COG1301; LUCA.
DR   GeneTree; ENSGT00940000159485; -.
DR   HOGENOM; HOG000208776; -.
DR   InParanoid; Q15758; -.
DR   KO; K05616; -.
DR   OMA; GNLIGNC; -.
DR   OrthoDB; 1340284at2759; -.
DR   PhylomeDB; Q15758; -.
DR   TreeFam; TF315206; -.
DR   Reactome; R-HSA-352230; Amino acid transport across the plasma membrane.
DR   ChiTaRS; SLC1A5; human.
DR   GeneWiki; SLC1A5; -.
DR   GenomeRNAi; 6510; -.
DR   Pharos; Q15758; Tchem.
DR   PRO; PR:Q15758; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q15758; protein.
DR   Bgee; ENSG00000105281; Expressed in 220 organ(s), highest expression level in urinary bladder.
DR   ExpressionAtlas; Q15758; baseline and differential.
DR   Genevisible; Q15758; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0015171; F:amino acid transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0015186; F:L-glutamine transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015194; F:L-serine transmembrane transporter activity; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0015175; F:neutral amino acid transmembrane transporter activity; TAS:ProtInc.
DR   GO; GO:0038023; F:signaling receptor activity; TAS:ProtInc.
DR   GO; GO:0015293; F:symporter activity; IEA:UniProtKB-KW.
DR   GO; GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0006865; P:amino acid transport; TAS:Reactome.
DR   GO; GO:0010585; P:glutamine secretion; IEA:Ensembl.
DR   GO; GO:0006868; P:glutamine transport; IDA:UniProtKB.
DR   GO; GO:1903803; P:L-glutamine import across plasma membrane; IEA:Ensembl.
DR   GO; GO:0015804; P:neutral amino acid transport; TAS:ProtInc.
DR   GO; GO:0070207; P:protein homotrimerization; IDA:UniProtKB.
DR   Gene3D; 1.10.3860.10; -; 1.
DR   InterPro; IPR001991; Na-dicarboxylate_symporter.
DR   InterPro; IPR018107; Na-dicarboxylate_symporter_CS.
DR   InterPro; IPR036458; Na:dicarbo_symporter_sf.
DR   Pfam; PF00375; SDF; 1.
DR   SUPFAM; SSF118215; SSF118215; 1.
DR   PROSITE; PS00713; NA_DICARBOXYL_SYMP_1; 1.
DR   PROSITE; PS00714; NA_DICARBOXYL_SYMP_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative initiation; Alternative splicing;
KW   Amino-acid transport; Cell membrane; Glycoprotein;
KW   Host cell receptor for virus entry; Host-virus interaction; Membrane;
KW   Metal-binding; Phosphoprotein; Polymorphism; Receptor; Reference proteome;
KW   Sodium; Symport; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..541
FT                   /note="Neutral amino acid transporter B(0)"
FT                   /id="PRO_0000202082"
FT   TOPO_DOM        1..51
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        52..81
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000305|PubMed:29872227"
FT   TOPO_DOM        82..94
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        95..116
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000305|PubMed:29872227"
FT   TOPO_DOM        117..130
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        131..153
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000305|PubMed:29872227"
FT   TOPO_DOM        154..224
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        225..248
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000305|PubMed:29872227"
FT   TOPO_DOM        249..257
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        258..285
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000305|PubMed:29872227"
FT   TOPO_DOM        286..306
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        307..328
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000305|PubMed:29872227"
FT   TOPO_DOM        329..333
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   INTRAMEM        334..364
FT                   /note="Discontinuously helical"
FT                   /evidence="ECO:0000305|PubMed:29872227"
FT   TOPO_DOM        365..373
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        374..400
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000305|PubMed:29872227"
FT   TOPO_DOM        401..413
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   INTRAMEM        414..447
FT                   /note="Discontinuously helical"
FT                   /evidence="ECO:0000305|PubMed:29872227"
FT   TOPO_DOM        448..460
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        461..482
FT                   /note="Helical; Name=8"
FT                   /evidence="ECO:0000305|PubMed:29872227"
FT   TOPO_DOM        483..541
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   METAL           382
FT                   /note="Sodium 1; via carbonyl oxygen"
FT                   /evidence="ECO:0000250|UniProtKB:O59010"
FT   METAL           384
FT                   /note="Sodium 2; via carbonyl oxygen"
FT                   /evidence="ECO:0000250|UniProtKB:P43003"
FT   METAL           386
FT                   /note="Sodium 1"
FT                   /evidence="ECO:0000250|UniProtKB:O59010"
FT   METAL           471
FT                   /note="Sodium 1; via carbonyl oxygen"
FT                   /evidence="ECO:0000250|UniProtKB:O59010"
FT   METAL           475
FT                   /note="Sodium 1"
FT                   /evidence="ECO:0000250|UniProtKB:O59010"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:22814378"
FT   MOD_RES         493
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         494
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         503
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         535
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332"
FT   MOD_RES         539
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   CARBOHYD        163
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        212
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19349973"
FT   VAR_SEQ         1..228
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046851"
FT   VAR_SEQ         1..203
FT                   /note="MVADPPRDSKGLAAAEPTANGGLALASIEDQGAAAGGYCGSRDQVRRCLRAN
FT                   LLVLLTVVAVVAGVALGLGVSGAGGALALGPERLSAFVFPGELLLRLLRMIILPLVVCS
FT                   LIGGAASLDPGALGRLGAWALLFFLVTTLLASALGVGLALALQPGAASAAINASVGAAG
FT                   SAENAPSKEVLDSFLDLARNIFPSNLVSAAFRS -> M (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046354"
FT   VARIANT         17
FT                   /note="P -> A (in dbSNP:rs3027956)"
FT                   /id="VAR_020439"
FT   VARIANT         512
FT                   /note="V -> L (in dbSNP:rs3027961)"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000269|PubMed:14702039"
FT                   /id="VAR_013517"
FT   CONFLICT        18..24
FT                   /note="TANGGLA -> PPTGAWQ (in Ref. 1; AAC50629)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        44
FT                   /note="Q -> L (in Ref. 1; AAC50629)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        84..87
FT                   /note="ERLS -> GALE (in Ref. 1; AAC50629)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        341
FT                   /note="V -> A (in Ref. 5; BAH14917)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        453
FT                   /note="I -> V (in Ref. 2; AAD09812)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        460
FT                   /note="D -> G (in Ref. 2; AAD09812)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        463
FT                   /note="V -> A (in Ref. 2; AAD09812)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        508
FT                   /note="D -> G (in Ref. 2; AAD09812)"
FT                   /evidence="ECO:0000305"
FT   HELIX           54..62
FT                   /evidence="ECO:0000244|PDB:5LM4"
FT   HELIX           66..69
FT                   /evidence="ECO:0000244|PDB:5LM4"
FT   HELIX           104..107
FT                   /evidence="ECO:0000244|PDB:5LM4"
FT   HELIX           180..191
FT                   /evidence="ECO:0000244|PDB:5LM4"
FT   HELIX           196..199
FT                   /evidence="ECO:0000244|PDB:5LM4"
FT   STRAND          202..204
FT                   /evidence="ECO:0000244|PDB:5LM4"
FT   STRAND          225..228
FT                   /evidence="ECO:0000244|PDB:5LM4"
FT   HELIX           231..237
FT                   /evidence="ECO:0000244|PDB:5LM4"
FT   HELIX           239..245
FT                   /evidence="ECO:0000244|PDB:5LM4"
FT   HELIX           254..261
FT                   /evidence="ECO:0000244|PDB:5LM4"
FT   HELIX           266..270
FT                   /evidence="ECO:0000244|PDB:5LM4"
FT   HELIX           324..329
FT                   /evidence="ECO:0000244|PDB:5LM4"
FT   HELIX           476..480
FT                   /evidence="ECO:0000244|PDB:5LM4"
SQ   SEQUENCE   541 AA;  56598 MW;  AD61C789CCFFE934 CRC64;
     MVADPPRDSK GLAAAEPTAN GGLALASIED QGAAAGGYCG SRDQVRRCLR ANLLVLLTVV
     AVVAGVALGL GVSGAGGALA LGPERLSAFV FPGELLLRLL RMIILPLVVC SLIGGAASLD
     PGALGRLGAW ALLFFLVTTL LASALGVGLA LALQPGAASA AINASVGAAG SAENAPSKEV
     LDSFLDLARN IFPSNLVSAA FRSYSTTYEE RNITGTRVKV PVGQEVEGMN ILGLVVFAIV
     FGVALRKLGP EGELLIRFFN SFNEATMVLV SWIMWYAPVG IMFLVAGKIV EMEDVGLLFA
     RLGKYILCCL LGHAIHGLLV LPLIYFLFTR KNPYRFLWGI VTPLATAFGT SSSSATLPLM
     MKCVEENNGV AKHISRFILP IGATVNMDGA ALFQCVAAVF IAQLSQQSLD FVKIITILVT
     ATASSVGAAG IPAGGVLTLA IILEAVNLPV DHISLILAVD WLVDRSCTVL NVEGDALGAG
     LLQNYVDRTE SRSTEPELIQ VKSELPLDPL PVPTEEGNPL LKHYRGPAGD ATVASEKESV
     M
//
